April 24, 2020

April 24, 2020

The coronavirus crisis shows the risks of scientific collaboration with China

Washington Post – April 23

In December, the Moffitt Cancer Center fired its chief executive and five other officials for not disclosing they were being paid by the Chinese government under its Thousand Talents recruitment program.

Blog: Updates from Thursday, April 23</a

WFTS – April 23

Moffitt Cancer Center is launching two COVID-19 studies looking at infection rates in Florida and Hillsborough County.

Jimmy Patronis asks Mike Pompeo for help identifying Chinese cash

Florida Politics – April 23

In February, the Moffitt Cancer Center agreed to return $1.1 million to DFS, money spent by a Moffitt scientist tied to an investigation into Chinese meddling.

Tampa partners with retailers to require essential workers wear face masks

Florida Politics – April 22

The city is partnering with Publix, Winn Dixie, Home Depot, Walmart, Sam’s Club, Target, Tampa Electric and TECO People’s Gas, CVS, Walgreens, Moffitt Cancer Center and AdventHealth to get facial coverings to employees whose work requires them to deal with the public.

Tampa Mayor Jane Castor announces mask partnership with retail heavyweights Publix, Target and more

Tampa Bay Times – April 22

Other participants include Winn Dixie, Walmart, Sam’s Club, Target, Tampa Electric and TECO People’s Gas, CVS Pharmacy, Moffitt Cancer Center and AdventHealth. 

Tampa Mayor Jane Castor teams up with local businesses to get face masks to employees

Creative Loafing – April 22

(Virtual) wedding bells: Charlotte County Clerk offers Zoom weddings

Charlotte Sun – April 22

“We were spending a lot of time at Moffitt Cancer Center. I applied for the license online because I knew what the end result of his cancer would be.”

Immunosuppression in Tumors Overall 

Oncology Tube – April 22

Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews explains immunosuppression in tumors overall in the study.

Paulo Rodriguez, PhD discusses Molecular Pathways Controlling Immunosuppression: What are the effects of activation?

Oncology Tube – April 22

Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews answers what the effects are in activation for identifying molecular pathways that control immunosuppression in tumors.

Paulo Rodriguez, PhD discusses Molecular Pathways Controlling Immunosuppression in Tumors

Oncology Tube – April 22

Paulo Rodriguez, PhD of Moffitt Cancer Center @MoffittNews discusses identifying molecular pathways that control immunosuppression in tumors.

Memgen, Moffitt licensing deal centers on tumor targeting candidate

BioWorld – April 21

Privately held Memgen LLC and the H. Lee Moffitt Cancer Center agreed to technology licensing agreements covering intellectual property the two jointly developed. 

ILLUMINATE-204 Update: Promising Results Reported With Tilsotolimod Plus Ipilimumab in Advanced Melanoma

Targeted Oncology – April 21

“The clinical benefit suggested for these anti-PD-1 refractory melanoma patients with limited treatment options includes stabilization of disease and even responses, which is creating hope that this combination might be of benefit to patients in the PD-1 refractory setting,” stated Joseph Markowitz, MD, PhD, from the H. Lee Moffitt Cancer Center & Research Center in Tampa, Florida.

Pepinemab Plus Avelumab Provides Disease Control in NSCLC

Medscape – April 21

Michael Rahman Shafique, MD, of Moffitt Cancer Center in Tampa, Fla., reported these results at the ASCO-SITC Clinical Immuno-Oncology Symposium.

Moffitt Foundation creates COVID-19 Frontline Response Fund

Tampa Bay Newspapers – April 21

 As patients continue to seek lifesaving care during the COVID-19 pandemic, Moffitt Cancer Center is doing everything possible to protect the immunocompromised, as well as its own health care team.

Cardio-oncology explosion: Increasing awareness, collaboration, research

Cardiology Today/Healio – April 2020

“Patients with cancer are living longer and, in many cases, surviving their disease,” Michael G. Fradley, MD, director of the cardio-oncology program and associate professor at University of South Florida College of Medicine and Moffitt Cancer Center in Tampa, who at press time was about to become medical director of cardio-oncology and associate professor of clinical medicine at University of Pennsylvania Perelman School of Medicine, told Cardiology Today.

PSA Dynamics and Response to Androgen-Deprivation Therapy

ASCO Post – April 20

“Continuous treatment by maximally selecting for resistant phenotypes and eliminating other competing populations may actually accelerate the emergence of resistant populations—a well-studied evolutionary phenomenon termed competitive release,” said senior study author Heiko Enderling, PhD, Associate Member of the Department of Integrated Mathematical Oncology at the Moffitt Cancer Center.

Pepinemab plus avelumab provides disease control in NSCLC

MD Edge – April 20

Michael Rahman Shafique, MD, of Moffitt Cancer Center in Tampa, Fla., reported these results at the ASCO-SITC Clinical Immuno-Oncology Symposium.

Tampa Deli Offers Free Dinners To Unemployed Restaurant Workers

Patch – April 20

On April 7, the Country Place neighborhood in Northdale presented health care workers in the intensive care unit at Moffitt Cancer Center with lunch from Cass Street Deli.

Memgen Announces Exclusive License Agreements With Moffitt Cancer Center to Develop Innovative Cancer Immunotherapies

AccessWire - April 20

Memgen, a private biotechnology company developing innovative immuno-oncology drugs and immune therapeutics, announced today that it has entered into technology licensing agreements with the Moffitt Cancer Center, a premier center for cancer research and care.

Warning from Front Lines</a

WFLA – April 19

All were on the front lines doctor john green is head of the infectious diseases division at Moffitt Cancer Center he tells 8 on your side ppe continues to be crucial, especially for health care workers and icy use any ours.

5 Things Not to Do When Delivering Bad News to Patients

The Doctor Weighs In – April 19

Dr. Jacques Fontaine, M.D. has been a thoracic surgeon for over 14 years.  He is a Senior Member of the Thoracic Oncology Department at the H. Lee Moffitt Cancer Center in Tampa, FL as well as a Professor at the University of South Florida.

Dose-Adjusted Regimen for B-Cell Lymphomas Deemed Cost Effective in Outpatient Setting

Journal of Clinical Pathways – April 17

Moffitt Cancer Center developed an inpatient/outpatient (IPOP) program to facilitate administration of complicated inpatient regimens in the outpatient setting.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.